CALL US:022-2204 0015 / 16 / 17   isa@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
Our Bureau, Mumbai August 01 , 2019
Eurolife Healthcare Pvt Ltd, one of the leading Indian specialty pharmaceutical, manufacturing and distribution companies, has taken over Teva’s intravenous (IV) infusions plant and operations, located in Hungary, for an undisclosed amount.

With this takeover, Eurolife has emerged as the first Indian company in the intravenous infusions business to set up manufacturing operations abroad.

The company had, in 2017, taken over American MNC Baxter’s India operations, and has strategic thrust on growth via takeovers and acquisitions worldwide.

Announcing the breakthrough, Sandeep Toshniwal, chief executive officer, Eurolife Healthcare Pvt Ltd, said, “Eurolife Healthcare will invest €50 million over the next three years to build one of the single largest IV plants in the world at this location.”

“The takeover of Teva’s Infusion plant, gives us a distinct competitive advantage and will help us emerge as the leading international player in the category. This acquisition will also help us tap and service our EU (European Union) and US markets for IVs in a better way,” he added.

Toshniwal also added that Eurolife was also adding massive capacities across its manufacturing plants in India to further increase its footprint in the Indian market along with exports.

Share This Story

Leave a Reply
Your name (required)   Your email (required)
         
Website (required)
   
CommenT
 
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
India needs to align with global good practices to reinvogorate its capability in pharmaceutical manufacture. The regula ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2013 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Internet Explorer(9.0) or Firefox(26.0)